Chlorambucil. 4-(Bis(2-chloroethyl)amino)benzenebutanoic Acid . Amboclorin . CB-1348 . Chloraminophene . Chlorbutin . Leukeran . Lympholysin . N,N-Di-(2-chloroethyl)-p-aminophenylbutyric Acid . NSC-3088 . CB 1348 . CB1348 . NSC 3088 . NSC3088 . A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed) . 1.00
Azathioprine. Azathioprine Sodium . Azathioprine Sodium Salt . Azathioprine Sulfate . Azothioprine . Immuran . Imuran . Imurel . Sodium, Azathioprine . An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) . 0.56
Diethylstilbestrol. Agostilben . Apstil . Diethylstilbestrol, (Z)-Isomer . Diethylstilbestrol, Disodium Salt . Distilbène . Stilbene Estrogen . Tampovagan . Estrogen, Stilbene . Stilbestrol . A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed) . 0.53
Thiotepa. AI3-24916 . Girostan . NSC-6396 . Tespa . Tespamin . Tris(1-aziridinyl)phosphine Sulfide . AI3 24916 . AI324916 . NSC 6396 . NSC6396 . Thio Tepa . Thiophosphamide . Thio-Tepa . Triethylenethiophosphoramide . A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed). . 0.52
Mustard Gas. Bis(beta-chloroethyl) Sulfide . Di-2-chloroethyl Sulfide . Mustardgas . Psoriazin . Yellow Cross Liquid . Yperite . Di 2 chloroethyl Sulfide . Gas, Mustard . Mustard, Sulfur . Sulfide, Di-2-chloroethyl . Sulfide, Dichlorodiethyl . Dichlorodiethyl Sulfide . Sulfur Mustard . Severe irritant and vesicant of skin, eyes, and lungs. It may cause blindness and lethal lung edema and was formerly used as a war gas. The substance has been proposed as a cytostatic and for treatment of psoriasis. It has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP-85-002, 1985) (Merck, 11th ed). . 0.49
Oxymetholone. Anadrol . Anapolon 50 . Oxymethalone . Oxymetholone, (17 beta)-Isomer . Oxymetholone, (5 alpha,17 alpha)-Isomer . Hydroxymetholone . A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens (NTP 85-002), this compound may reasonably be anticipated to be a carcinogen. (From Merck Index, 11th ed) . 0.48
Busulfan. Busulfan Wellcome . Busulfex . Glyzophrol . Myelosan . Mylecytan . Myleran . Myléran . n-Butane-1,3-di(methylsulfonate) . Wellcome, Busulfan . Busulphan . An alkylating agent having a selective immunosuppressive effect on BONE MARROW. It has been used in the palliative treatment of chronic myeloid leukemia (MYELOID LEUKEMIA, CHRONIC), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. . 0.46
Arsenic. Arsenic-75 . Arsenic 75 . A shiny gray element with atomic symbol As, atomic number 33, and atomic weight 75. It occurs throughout the universe, mostly in the form of metallic arsenides. Most forms are toxic. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), arsenic and certain arsenic compounds have been listed as known carcinogens. (From Merck Index, 11th ed) . 0.44
Carmustine. 1,3-Bis(2-Chloroethyl)-1-Nitrosourea . BiCNU . FIVB 1834 . N,N'-Bis(2-Chloroethyl)-N-Nitrosourea . Nitrumon . BCNU 1834 . A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) . 0.42